Anita
is a real patient
with RA, performing
an everyday activity...
Welcome to ACTEMRA World
This website is intended for healthcare professionals and is an extensive resource site for healthcare professionals outside the US with an interest in rheumatoid arthritis (RA) and its treatment with ACTEMRA® (tocilizumab), a first-in-class agent with a novel mechanism of action that targets the interleukin-6 (IL-6) receptor.
The product is known as RoACTEMRA in the EU and Mexico and as ACTEMRA in other countries.
This site contains, amongst other things, information on the mechanisms of action of ACTEMRA, guides to dosing and administration, and efficacy and safety data from key Phase III clinical trials. There is also a useful resource section containing a range of downloadable materials on RA and ACTEMRA.
This website became live early in 2009, coinciding with the approval of ACTEMRA in Europe. In addition to the facilities already available, there are many others planned or under construction. Please keep coming back to the site for the latest information on ACTEMRA and RA.
About ACTEMRA
This section contains detailed scientific and medical information on ACTEMRA, including the mechanisms of action, dosage and administration details, and safety and efficacy information from key clinical trials. More...
Resources
Within this section there is a wealth of useful information and practical items relating to the treatment of rheumatoid arthritis (RA) and the use of ACTEMRA. As well as printable charts and brochures, there will be soon links to journals, congress materials and highlights and general information on RA available. More...